Skip to content
August 15, 2022

Equity.Guru

Investment information for the new generation

September 2, 2021

Filament Health (FH.NEO) filed their 20th patent application for their research phase programs, including three international Patent Cooperation Treaty (PCT) applications, earlier this week, according to a press release….
Just a few days ago, I discussed my experience buying a NFT for the first time. I highlighted the Ethereum ecosystem. Being able to do and purchase certain things…
In this episode, we talk about DIAGNOS (ADK.V), a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging, and traditional data mining thereby improving decision…
Chris Parry speaks with Andre Larente, president and CEO of DIAGNOS (ADK.V) to get an in-depth look at how their diabetic retinopathy screening services work and what it means…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Diagnos (ADK.V) is definitely one of the companies with the coolest AI tech I have come across. I would use the word disruptive. And I like disruptive. I am…
Diagnos (ADK.V) today announced a contract renewal to provide its telemedicine platform based on CARA (Computer Assisted Retina Analysis) to Optina Diagnostics for an additional three-year period. “This contract…
In light of recent trading action—an early August flash crash followed by a nice stair-stepping sequence higher—we may have printed a bottom in the precious metal arena, and a…
It seems like every few days I stumble across a new name in the psychedelics industry I hadn’t heard before. Usually smaller deals just getting off the ground. But,…
Fandom Sports Media (FDM.C) enlisted the assistance of Phantom Compliance to help them set up the internal controls and structures to support their business-to-business Malta critical gaming license application,…